Stay updated on Reirradiation With Pembrolizumab in Head-and-Neck Clinical Trial

Sign up to get notified when there's something new on the Reirradiation With Pembrolizumab in Head-and-Neck Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Reirradiation With Pembrolizumab in Head-and-Neck Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Footer revision updated to v3.3.2, replacing the previous v3.3.1.
    Difference
    0.1%
    Check dated 2025-12-01T17:52:05.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision: v3.3.1 replaces the previous v3.2.0 on the page. No substantive study details or functionality changes are indicated.
    Difference
    0.1%
    Check dated 2025-11-24T14:47:37.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    Deleted the government funding lapse notice that was previously displayed on the page; it had directed users to cc.nih.gov and opm.gov for operating status updates.
    Difference
    0.4%
    Check dated 2025-11-17T06:55:10.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Results for NCT02289209 were posted on ClinicalTrials.gov on 2025-03-06, including updated outcome measures and data tables.
    Difference
    0.4%
    Check dated 2025-11-03T01:19:47.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Major change: new government operating status notice and updated version to v3.2.0. Minor changes: removal of a specific resource title and old version label.
    Difference
    3%
    Check dated 2025-10-05T10:23:16.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Reworded the core topic to 'Squamous cell carcinoma of the head and neck' and updated the revision/version to v3.1.0.
    Difference
    0.5%
    Check dated 2025-09-28T03:20:20.000Z thumbnail image

Stay in the know with updates to Reirradiation With Pembrolizumab in Head-and-Neck Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Reirradiation With Pembrolizumab in Head-and-Neck Clinical Trial page.